Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Kumar A, et al. Polymer-based hybrid nanoarchitectures for cancer therapy applications. Polymers. 2022;14(15):3027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Durme R, et al. Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery. Drug Deliv. 2021;28(1):63–76.

Article  PubMed  Google Scholar 

Mirza S, et al. Magnetic nanoparticles: drug delivery and bioimaging applications. In: Metal nanoparticles for drug delivery and diagnostic applications. Elsevier; 2020. p. 189–213.

Chapter  Google Scholar 

Price PM, et al. Magnetic drug delivery: where the field is going. Front Chem. 2018:619.

Liu JF, et al. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(6):e1571.

Article  PubMed  PubMed Central  Google Scholar 

Bilal M, et al. Stimuli-responsive nanoliposomes as prospective nanocarriers for targeted drug delivery. J Drug Deliv Sci Technol. 2021;66:102916.

Article  CAS  Google Scholar 

Yan B, et al. Engineering magnetic nano-manipulators for boosting cancer immunotherapy. J Nanobiotechnol. 2022;20(1):547.

Article  CAS  Google Scholar 

Tenchov R, et al. Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982–7015.

Article  CAS  PubMed  Google Scholar 

Pandey H, Rani R, Agarwal V. Liposome and their applications in cancer therapy. Braz Arch Biol Technol. 2016;59.

Dash S, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.

CAS  PubMed  Google Scholar 

Santadkha T, Skolpap W, Thitapakorn V. Diffusion modeling and in vitro release kinetics studies of curcumin− loaded superparamagnetic nanomicelles in cancer drug delivery system. J Pharm Sci. 2022;111:1690–99.

Lu T, Ten Hagen TL. A novel kinetic model to describe the ultra-fast triggered release of thermosensitive liposomal drug delivery systems. J Control Release. 2020;324:669–78.

Article  CAS  PubMed  Google Scholar 

Al Sabah A, Maghdoon R. Determination of cytotoxicity of anticancer drug doxorubicin and its side effects. Medbiotech J. 2021;5(01):1–5.

Google Scholar 

Bassiony H, et al. Magnetite nanoparticles inhibit tumor growth and upregulate the expression of P53/P16 in Ehrlich solid carcinoma bearing mice. PLoS One. 2014;9(11): e111960.

Article  PubMed  PubMed Central  Google Scholar 

Zhu J, Wang J, Li Y. Recent advances in magnetic nanocarriers for tumor treatment. Biomed Pharmacother. 2023;159: 114227.

Article  CAS  PubMed  Google Scholar 

Sadeghi-Aliabadi H, et al. Preparation and cytotoxic evaluation of magnetite (Fe3O4) nanoparticles on breast cancer cells and its combinatory effects with doxorubicin used in hyperthermia. Avicenna J Med Biotechnol. 2013;5(2):96.

CAS  PubMed  PubMed Central  Google Scholar 

Van Durme R, et al. Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery. Drug Deliv. 2021;28(1):63–76.

Article  PubMed  Google Scholar 

Coene A, et al. Multi-color magnetic nanoparticle imaging using magnetorelaxometry. Phys Med Biol. 2017;62(8):3139–57.

Article  CAS  PubMed  Google Scholar 

Jannah N, Onggo D. Synthesis of Fe3O4 nanoparticles for colour removal of printing ink solution. Journal of Physics: Conference Series. 2019;1245:012040. 

Sadighian S, et al. Doxorubicin-conjugated core–shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery. Colloids Surf B. 2014;117:406–13.

Article  CAS  Google Scholar 

Ibrahim M, et al. Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: a review. Pharmaceutics. 2022;14(2):254.‏

Fadeel DAA, et al. Novel greenly synthesized titanium dioxide nanoparticles compared to liposomes in drug delivery: in vivo investigation on Ehrlich solid tumor model. Heliyon. 2021;7(6): e07370.

Article  PubMed  PubMed Central  Google Scholar 

Bakre LG, Sarvaiya JI, Agrawal YK. Synthesis, characterization, and study of drug release properties of curcumin from polycaprolactone/organomodified montmorillonite nanocomposite. J Pharm Innov. 2016;11(4):300–7.

Article  Google Scholar 

de Oliveira Silva J, et al. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model. Biomed Pharmacother. 2019;118: 109323.

Article  PubMed  PubMed Central  Google Scholar 

Cao D, et al. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer. Artificial Cells Nanomed Biotechnol. 2019;47(1):181–91.

Article  CAS  Google Scholar 

Monteiro LO, et al. Paclitaxel-loaded pH-sensitive liposome: new insights on structural and physicochemical characterization. Langmuir. 2018;34(20):5728–37.

Article  CAS  PubMed  Google Scholar 

Huang R, et al. Imidazole-based pH-sensitive convertible liposomes for anticancer drug delivery. Pharmaceuticals. 2022;15(3):306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dadashi R, Bahram M, Moghtader M. Multivariate curve resolution-alternating least squares to study the simultaneous release of Sumatriptan and Naproxen from the polymeric substrate. J Iran Chem Soc. 2020;17(4):953–62.

Article  CAS  Google Scholar 

Ding Y, et al. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors. Drug Des Dev Ther. 2017;11:3105.

Article  CAS  Google Scholar 

Ghandhariyoun N, et al. Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: in vitro and in vivo. Life Sci. 2020;262: 118520.

Article  CAS  PubMed  Google Scholar 

Dorjsuren B, et al. Cetuximab-coated thermo-sensitive liposomes loaded with magnetic nanoparticles and doxorubicin for targeted EGFR-expressing breast cancer combined therapy. Int J Nanomed. 2020;15:8201.

Article  CAS  Google Scholar